Del Carmen Jeffrey (CIK 1816477) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-17). Recent activity: Sell CPRX (14,337 shares), Buy CPRX (8,667 shares), Sell CPRX (3,839 shares), Buy CPRX (8,039 shares), Sell CPRX (2,492 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-17 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Commercial Officer | Sell | 14,337 | $451,616 |
| 2025-12-30 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Commercial Officer | Buy | 8,667 | $0 |
| 2025-12-30 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Commercial Officer | Sell | 3,839 | $0 |
| 2025-12-10 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Commercial Officer | Buy | 8,039 | $0 |
| 2025-12-10 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Commercial Officer | Sell | 2,492 | $0 |
| 2025-11-28 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Commercial Officer | Buy | 10,983 | $46,238 |
| 2025-11-28 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Commercial Officer | Sell | 10,983 | $256,233 |
| 2025-11-24 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Commercial Officer | Buy | 5,603 | $0 |
| 2025-11-24 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Commercial Officer | Sell | 1,641 | $0 |
| 2025-03-05 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Chief Commercial Officer | Sell | 30,423 | $696,382 |
Source: SEC Form 4 filings · as of 2026-07-17